Rupak Pathak
Concepts (250)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosome Aberrations | 8 | 2024 | 297 | 2.800 |
Why?
| Radiation Injuries | 8 | 2024 | 113 | 2.480 |
Why?
| Human Umbilical Vein Endothelial Cells | 5 | 2024 | 90 | 2.480 |
Why?
| Thrombomodulin | 4 | 2020 | 27 | 2.320 |
Why?
| Vitamin E | 7 | 2021 | 81 | 2.120 |
Why?
| In Situ Hybridization, Fluorescence | 4 | 2024 | 259 | 1.830 |
Why?
| Translocation, Genetic | 4 | 2024 | 264 | 1.670 |
Why?
| Chromosome Banding | 3 | 2024 | 24 | 1.370 |
Why?
| Radiation, Ionizing | 8 | 2022 | 100 | 1.370 |
Why?
| Chromans | 4 | 2021 | 37 | 1.350 |
Why?
| DNA Damage | 8 | 2024 | 301 | 1.330 |
Why?
| Tocotrienols | 4 | 2019 | 37 | 1.320 |
Why?
| Mice | 27 | 2024 | 5739 | 1.070 |
Why?
| Animals | 37 | 2024 | 13187 | 1.040 |
Why?
| Methionine | 3 | 2021 | 135 | 1.030 |
Why?
| Bone Marrow Cells | 5 | 2021 | 191 | 1.030 |
Why?
| Intestines | 5 | 2022 | 176 | 1.030 |
Why?
| Radiation-Protective Agents | 4 | 2021 | 74 | 0.950 |
Why?
| Chromosomes | 1 | 2024 | 32 | 0.930 |
Why?
| Intestine, Small | 2 | 2021 | 109 | 0.900 |
Why?
| Kruppel-Like Transcription Factors | 2 | 2020 | 36 | 0.850 |
Why?
| Mosaicism | 1 | 2022 | 18 | 0.830 |
Why?
| Spleen | 2 | 2020 | 172 | 0.820 |
Why?
| Intestinal Diseases | 2 | 2019 | 25 | 0.800 |
Why?
| Chromosome Painting | 3 | 2019 | 6 | 0.790 |
Why?
| Radiation Protection | 1 | 2021 | 47 | 0.790 |
Why?
| Duodenum | 1 | 2021 | 35 | 0.780 |
Why?
| Jejunum | 1 | 2021 | 54 | 0.770 |
Why?
| Ileum | 1 | 2021 | 89 | 0.760 |
Why?
| Spectral Karyotyping | 2 | 2019 | 6 | 0.750 |
Why?
| Proteome | 1 | 2022 | 173 | 0.750 |
Why?
| Weightlessness Simulation | 1 | 2020 | 19 | 0.740 |
Why?
| DNA | 1 | 2024 | 541 | 0.730 |
Why?
| Thymus Gland | 1 | 2020 | 42 | 0.730 |
Why?
| Gamma Rays | 1 | 2020 | 49 | 0.720 |
Why?
| Mice, Inbred C57BL | 15 | 2022 | 1816 | 0.710 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2020 | 78 | 0.690 |
Why?
| Thrombosis | 2 | 2024 | 248 | 0.690 |
Why?
| Malnutrition | 1 | 2021 | 87 | 0.690 |
Why?
| Particulate Matter | 2 | 2016 | 52 | 0.690 |
Why?
| Chromosome Breakpoints | 1 | 2019 | 5 | 0.690 |
Why?
| Simvastatin | 1 | 2019 | 29 | 0.660 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 138 | 0.660 |
Why?
| Abdominal Neoplasms | 1 | 2019 | 16 | 0.660 |
Why?
| Pelvic Neoplasms | 1 | 2019 | 14 | 0.650 |
Why?
| Whole-Body Irradiation | 7 | 2021 | 131 | 0.640 |
Why?
| Lymphocytes | 2 | 2022 | 152 | 0.630 |
Why?
| Hematopoietic Stem Cells | 5 | 2017 | 184 | 0.620 |
Why?
| DNA Probes | 2 | 2017 | 30 | 0.610 |
Why?
| Drug Therapy, Combination | 1 | 2019 | 377 | 0.600 |
Why?
| Plant Extracts | 1 | 2019 | 190 | 0.550 |
Why?
| Cell Culture Techniques | 1 | 2016 | 99 | 0.540 |
Why?
| Oxidative Stress | 7 | 2024 | 770 | 0.540 |
Why?
| Hematopoiesis | 2 | 2017 | 71 | 0.530 |
Why?
| Blood Cells | 2 | 2015 | 43 | 0.530 |
Why?
| Cytogenetic Analysis | 3 | 2024 | 82 | 0.520 |
Why?
| Recombinant Proteins | 1 | 2016 | 486 | 0.490 |
Why?
| Carrier Proteins | 2 | 2014 | 304 | 0.490 |
Why?
| Gene Expression Regulation | 7 | 2020 | 976 | 0.490 |
Why?
| Dose-Response Relationship, Radiation | 6 | 2020 | 184 | 0.490 |
Why?
| Chromosomes, Human | 1 | 2014 | 41 | 0.460 |
Why?
| Humans | 20 | 2024 | 49974 | 0.460 |
Why?
| Apoptosis | 5 | 2017 | 1101 | 0.450 |
Why?
| Oxygen | 3 | 2021 | 326 | 0.400 |
Why?
| Cytogenetics | 2 | 2022 | 23 | 0.380 |
Why?
| Radioisotopes | 2 | 2007 | 16 | 0.360 |
Why?
| Male | 21 | 2022 | 25241 | 0.340 |
Why?
| DNA Methylation | 4 | 2020 | 548 | 0.340 |
Why?
| Heavy Ions | 2 | 2015 | 15 | 0.330 |
Why?
| Inflammation | 2 | 2024 | 604 | 0.320 |
Why?
| Dose-Response Relationship, Drug | 5 | 2020 | 1376 | 0.320 |
Why?
| Gastrointestinal Tract | 3 | 2022 | 103 | 0.320 |
Why?
| Radiation Injuries, Experimental | 3 | 2020 | 81 | 0.310 |
Why?
| Intestinal Mucosa | 2 | 2021 | 225 | 0.300 |
Why?
| DNA Repair | 2 | 2021 | 193 | 0.300 |
Why?
| Lithium Compounds | 1 | 2007 | 11 | 0.290 |
Why?
| Oxygen Radioisotopes | 1 | 2007 | 14 | 0.290 |
Why?
| Protein Binding | 3 | 2021 | 660 | 0.290 |
Why?
| Carbon Radioisotopes | 1 | 2007 | 53 | 0.290 |
Why?
| Macrophages | 3 | 2021 | 363 | 0.290 |
Why?
| Metaphase | 3 | 2016 | 44 | 0.290 |
Why?
| Lithium | 1 | 2007 | 34 | 0.290 |
Why?
| Long Interspersed Nucleotide Elements | 2 | 2017 | 38 | 0.280 |
Why?
| Cell Line | 3 | 2016 | 1000 | 0.280 |
Why?
| Dietary Supplements | 2 | 2020 | 443 | 0.280 |
Why?
| Lasers | 1 | 2007 | 123 | 0.270 |
Why?
| Mice, Inbred CBA | 3 | 2021 | 35 | 0.270 |
Why?
| Radiation Tolerance | 2 | 2019 | 85 | 0.270 |
Why?
| Cells, Cultured | 4 | 2016 | 1573 | 0.270 |
Why?
| Epigenesis, Genetic | 3 | 2022 | 374 | 0.250 |
Why?
| Fluorescent Dyes | 2 | 2017 | 102 | 0.250 |
Why?
| Radiation Dosage | 3 | 2021 | 157 | 0.240 |
Why?
| Mitochondria | 2 | 2022 | 402 | 0.240 |
Why?
| Antioxidants | 2 | 2016 | 249 | 0.240 |
Why?
| Receptors, Purinergic | 1 | 2024 | 12 | 0.240 |
Why?
| Liver Diseases | 1 | 2024 | 78 | 0.230 |
Why?
| Endothelial Cells | 2 | 2024 | 269 | 0.230 |
Why?
| Metabolome | 2 | 2014 | 89 | 0.210 |
Why?
| Reactive Oxygen Species | 2 | 2022 | 408 | 0.210 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2015 | 142 | 0.210 |
Why?
| Monocytes | 2 | 2021 | 131 | 0.210 |
Why?
| Karyotyping | 1 | 2022 | 83 | 0.210 |
Why?
| Rodentia | 1 | 2022 | 18 | 0.200 |
Why?
| Blood Platelets | 1 | 2024 | 245 | 0.200 |
Why?
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2021 | 49 | 0.200 |
Why?
| Gene Expression | 2 | 2015 | 609 | 0.200 |
Why?
| Primates | 1 | 2021 | 20 | 0.200 |
Why?
| Body Weight | 2 | 2020 | 513 | 0.200 |
Why?
| Macaca mulatta | 1 | 2021 | 93 | 0.190 |
Why?
| HEK293 Cells | 2 | 2019 | 222 | 0.190 |
Why?
| Renal Insufficiency, Chronic | 1 | 2024 | 169 | 0.190 |
Why?
| DNA Breaks, Double-Stranded | 3 | 2016 | 72 | 0.190 |
Why?
| Catecholamines | 1 | 2020 | 46 | 0.180 |
Why?
| Drinking | 1 | 2020 | 38 | 0.180 |
Why?
| Disease Models, Animal | 4 | 2019 | 1455 | 0.180 |
Why?
| Mitogen-Activated Protein Kinase 7 | 1 | 2020 | 5 | 0.180 |
Why?
| Survival Analysis | 2 | 2019 | 653 | 0.180 |
Why?
| Radiation | 1 | 2020 | 15 | 0.180 |
Why?
| Abdomen | 1 | 2020 | 76 | 0.180 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2020 | 63 | 0.180 |
Why?
| Acute Radiation Syndrome | 1 | 2020 | 12 | 0.180 |
Why?
| Flow Cytometry | 3 | 2017 | 476 | 0.170 |
Why?
| Protons | 2 | 2017 | 69 | 0.170 |
Why?
| Energy Intake | 1 | 2020 | 170 | 0.170 |
Why?
| Proteomics | 1 | 2022 | 329 | 0.170 |
Why?
| Stress, Physiological | 1 | 2020 | 170 | 0.170 |
Why?
| Neoplasms | 2 | 2020 | 1235 | 0.170 |
Why?
| Stem Cells | 2 | 2017 | 171 | 0.170 |
Why?
| Time Factors | 5 | 2016 | 2903 | 0.170 |
Why?
| Garlic | 1 | 2019 | 5 | 0.170 |
Why?
| Bone Resorption | 1 | 2022 | 304 | 0.170 |
Why?
| Ascorbic Acid | 1 | 2019 | 24 | 0.160 |
Why?
| Signal Transduction | 3 | 2024 | 1618 | 0.160 |
Why?
| Curcumin | 1 | 2019 | 16 | 0.160 |
Why?
| Gene Rearrangement | 1 | 2019 | 74 | 0.160 |
Why?
| Osteoclasts | 1 | 2022 | 425 | 0.160 |
Why?
| Mice, Transgenic | 3 | 2016 | 555 | 0.150 |
Why?
| Up-Regulation | 2 | 2016 | 452 | 0.150 |
Why?
| RNA, Messenger | 3 | 2020 | 1105 | 0.150 |
Why?
| Fibrinogen | 1 | 2017 | 31 | 0.150 |
Why?
| Occupational Exposure | 1 | 2019 | 122 | 0.150 |
Why?
| Micronucleus Tests | 2 | 2007 | 6 | 0.150 |
Why?
| Cell Separation | 2 | 2016 | 89 | 0.150 |
Why?
| Cricetulus | 2 | 2007 | 97 | 0.140 |
Why?
| Lung | 3 | 2016 | 486 | 0.140 |
Why?
| Diet | 1 | 2021 | 566 | 0.140 |
Why?
| Cricetinae | 2 | 2007 | 192 | 0.140 |
Why?
| DNA Fragmentation | 2 | 2007 | 55 | 0.140 |
Why?
| Peroxidase | 1 | 2016 | 15 | 0.140 |
Why?
| Neutrophil Infiltration | 1 | 2016 | 26 | 0.140 |
Why?
| Drug Synergism | 1 | 2016 | 150 | 0.140 |
Why?
| Female | 6 | 2022 | 26472 | 0.140 |
Why?
| DNA Repair Enzymes | 1 | 2016 | 44 | 0.140 |
Why?
| Peroxynitrous Acid | 2 | 2013 | 32 | 0.130 |
Why?
| Recombinational DNA Repair | 1 | 2015 | 9 | 0.130 |
Why?
| PTEN Phosphohydrolase | 1 | 2016 | 55 | 0.130 |
Why?
| Myeloproliferative Disorders | 1 | 2016 | 27 | 0.130 |
Why?
| Endodeoxyribonucleases | 1 | 2015 | 44 | 0.130 |
Why?
| Homologous Recombination | 1 | 2015 | 40 | 0.130 |
Why?
| Transforming Growth Factor beta | 1 | 2016 | 144 | 0.130 |
Why?
| Metabolomics | 2 | 2014 | 126 | 0.130 |
Why?
| Genomic Instability | 1 | 2015 | 92 | 0.130 |
Why?
| Endothelium | 1 | 2015 | 39 | 0.130 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 595 | 0.130 |
Why?
| Cell Survival | 2 | 2007 | 600 | 0.120 |
Why?
| Collagen | 1 | 2016 | 206 | 0.120 |
Why?
| Models, Animal | 1 | 2015 | 233 | 0.120 |
Why?
| Liver | 2 | 2024 | 1115 | 0.120 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2014 | 22 | 0.120 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2014 | 25 | 0.120 |
Why?
| DNA Helicases | 1 | 2015 | 143 | 0.110 |
Why?
| Gene Order | 1 | 2013 | 13 | 0.110 |
Why?
| Leukocyte Count | 1 | 2013 | 70 | 0.110 |
Why?
| Gene Targeting | 1 | 2013 | 29 | 0.110 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 30 | 0.110 |
Why?
| Microscopy, Fluorescence | 1 | 2014 | 162 | 0.110 |
Why?
| Linear Energy Transfer | 2 | 2015 | 14 | 0.110 |
Why?
| Leukemia | 1 | 2013 | 65 | 0.110 |
Why?
| Rats, Sprague-Dawley | 1 | 2016 | 1597 | 0.100 |
Why?
| Mice, Knockout | 1 | 2015 | 841 | 0.100 |
Why?
| MicroRNAs | 1 | 2016 | 353 | 0.100 |
Why?
| Glutathione | 1 | 2013 | 295 | 0.100 |
Why?
| Cytokines | 1 | 2015 | 612 | 0.100 |
Why?
| Liver Cirrhosis | 1 | 2014 | 218 | 0.100 |
Why?
| Rats | 1 | 2016 | 3305 | 0.090 |
Why?
| Models, Biological | 1 | 2013 | 727 | 0.090 |
Why?
| Mutation | 1 | 2015 | 1294 | 0.080 |
Why?
| Histones | 3 | 2016 | 312 | 0.080 |
Why?
| Blood Cell Count | 2 | 2017 | 37 | 0.070 |
Why?
| Cell Death | 1 | 2007 | 181 | 0.070 |
Why?
| Radiotherapy Dosage | 1 | 2007 | 244 | 0.070 |
Why?
| MAP Kinase Signaling System | 2 | 2016 | 119 | 0.060 |
Why?
| Purinergic Antagonists | 1 | 2024 | 7 | 0.060 |
Why?
| Hemostasis | 1 | 2024 | 55 | 0.060 |
Why?
| Lipid Metabolism | 2 | 2014 | 175 | 0.050 |
Why?
| Cell Respiration | 1 | 2022 | 41 | 0.050 |
Why?
| Permeability | 1 | 2022 | 68 | 0.050 |
Why?
| Sirtuin 3 | 1 | 2022 | 19 | 0.050 |
Why?
| Tight Junctions | 1 | 2019 | 24 | 0.040 |
Why?
| Transcriptome | 1 | 2020 | 315 | 0.040 |
Why?
| Energy Metabolism | 1 | 2020 | 282 | 0.040 |
Why?
| Retroelements | 1 | 2017 | 14 | 0.040 |
Why?
| Species Specificity | 1 | 2017 | 192 | 0.040 |
Why?
| Fibrosis | 1 | 2017 | 179 | 0.040 |
Why?
| Azacitidine | 1 | 2016 | 34 | 0.030 |
Why?
| Arkansas | 1 | 2022 | 1977 | 0.030 |
Why?
| Neurofibromin 1 | 1 | 2016 | 11 | 0.030 |
Why?
| Blood Glucose | 1 | 2019 | 439 | 0.030 |
Why?
| DNA End-Joining Repair | 1 | 2015 | 13 | 0.030 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 83 | 0.030 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 56 | 0.030 |
Why?
| DNA, Satellite | 1 | 2015 | 11 | 0.030 |
Why?
| Interleukin-13 | 1 | 2015 | 15 | 0.030 |
Why?
| ras Proteins | 1 | 2016 | 64 | 0.030 |
Why?
| Escherichia coli Proteins | 1 | 2015 | 56 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2015 | 96 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2016 | 116 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2015 | 107 | 0.030 |
Why?
| Epigenomics | 1 | 2015 | 67 | 0.030 |
Why?
| Cell Cycle | 1 | 2016 | 231 | 0.030 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 157 | 0.030 |
Why?
| Cell Movement | 1 | 2016 | 247 | 0.030 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2016 | 202 | 0.030 |
Why?
| Iron | 1 | 2015 | 122 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 181 | 0.030 |
Why?
| Hematologic Neoplasms | 1 | 2016 | 99 | 0.030 |
Why?
| Myeloid Cells | 1 | 2014 | 38 | 0.030 |
Why?
| Lipid Peroxidation | 1 | 2014 | 100 | 0.030 |
Why?
| Mitosis | 1 | 2014 | 91 | 0.030 |
Why?
| Membrane Proteins | 1 | 2016 | 341 | 0.030 |
Why?
| Insulin | 1 | 2016 | 457 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2014 | 116 | 0.030 |
Why?
| Citrulline | 1 | 2014 | 95 | 0.030 |
Why?
| Phthalazines | 1 | 2013 | 20 | 0.030 |
Why?
| Metabolic Networks and Pathways | 1 | 2013 | 89 | 0.030 |
Why?
| RNA, Small Interfering | 1 | 2013 | 215 | 0.030 |
Why?
| Cluster Analysis | 1 | 2013 | 235 | 0.030 |
Why?
| Piperazines | 1 | 2013 | 117 | 0.030 |
Why?
| Acute Disease | 1 | 2013 | 366 | 0.030 |
Why?
| Risk Factors | 1 | 2020 | 3613 | 0.020 |
Why?
| GTP Cyclohydrolase | 1 | 2010 | 4 | 0.020 |
Why?
| Fibroblasts | 1 | 2013 | 345 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2010 | 23 | 0.020 |
Why?
| Nitric Oxide Synthase | 1 | 2010 | 75 | 0.020 |
Why?
| Indoles | 1 | 2013 | 278 | 0.020 |
Why?
| Biological Availability | 1 | 2010 | 122 | 0.020 |
Why?
| Obesity | 1 | 2019 | 1113 | 0.020 |
Why?
| Random Allocation | 1 | 2010 | 281 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2010 | 369 | 0.020 |
Why?
| Endothelium, Vascular | 1 | 2010 | 252 | 0.020 |
Why?
|
|
Pathak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|